Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-27

Clinical Trial Update: The POST-ACS Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for the POST-ACS study, involving patients with diabetes mellitus and acute coronary syndrome, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Swansea Bay University Health Board | Conditions: Diabetes Mellitus, Acute Coronary Syndrome | Phase 4 | Status: UNKNOWN